Back
Alnylam Pharmaceuticals Vs. CRISPR Therapeutics AG Industry Stock Comparison
Buy
55
ALNY
Alnylam Pharmaceuticals
Last Price:
$267.62
Seasonality Move:
25.91%
Sell
31
CRSP
CRISPR Therapeutics AG
Last Price:
$35.60
Seasonality Move:
22.33%
Buy
55
Alnylam Pharmaceuticals (ALNY)
is a Buy
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals [ALNY] share price is $266.86. The Score for ALNY is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
ALNY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
31
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy, Sell or Hold?
-
The current CRISPR Therapeutics AG [CRSP] share price is $37.22. The Score for CRSP is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
-
CRSP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $266.86Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRSP Stock Price Chart
What is CRISPR Therapeutics AG's stock price today?
-
The CRISPR Therapeutics AG share price today is $37.22The current trend is moderately bearish and CRSP is experiencing slight buying pressure.
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.93 | Buy |
| Relative Strength Index (14 RSI): | 55.31 | Buy |
| Chaikin Money Flow: | 459021 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (233.87 - 264.49) | Buy |
| Bollinger Bands (100): | (237.56 - 268.76) | Buy |
CRSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.76 | Buy |
| Relative Strength Index (14 RSI): | 49.84 | Sell |
| Chaikin Money Flow: | 315093 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.06 - 39.14) | Buy |
| Bollinger Bands (100): | (36.48 - 44.34) | Sell |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 265.73 | Buy |
| 20-day SMA: | 252.89 | Buy |
| 50-day SMA: | 252.29 | Buy |
| 200-day SMA: | 259.41 | Buy |
| 8-day EMA: | 263.42 | Buy |
| 20-day EMA: | 257.65 | Buy |
| 50-day EMA: | 254.38 | Buy |
| 200-day EMA: | 246.22 | Buy |
CRSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.23 | Buy |
| 20-day SMA: | 37.45 | Sell |
| 50-day SMA: | 38.42 | Sell |
| 200-day SMA: | 44.63 | Sell |
| 8-day EMA: | 36.62 | Buy |
| 20-day EMA: | 36.02 | Buy |
| 50-day EMA: | 28.85 | Buy |
| 200-day EMA: | 11.69 | Buy |
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.15 per share, an increase next quarter of $1.52 per share, an increase this year of $1.31 per share, and an increase next year of $2.89 per share.
CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, an increase next quarter of $0.15 per share, a decrease this year of $0.24 per share, and an increase next year of $1.00 per share.
Alnylam Pharmaceuticals Technical Analysis
| Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
CRISPR Therapeutics AG Technical Analysis
| Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||